FDA Device recall Z-1202-2020
FlexTip Plus Epidural Catheterization Set, Product Code JC-05400-DCS
- FDA Device
- Class II
- terminated
- Published 2020-02-19
On 2020-02-19 the FDA classified a Class II recall of FlexTip Plus Epidural Catheterization Set, Product Code JC-05400-DCS by Arrow International, citing there is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1202-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-01-15 |
| Published | 2020-02-19 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Arrow International |
| Distribution | AK, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, LA, MA, MD, MI, MN, MO, MT, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WY |
Product
FlexTip Plus Epidural Catheterization Set, Product Code JC-05400-DCS
Reason
There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
Identifiers
| code_info | Lots: 71F19B0226 71F19B2848 71F19D0451 71F19E0081 71F19F0245 71F19J1235 71F19B0707 71F19C0406 71F19D0826 71F19…Lots: 71F19B0226 71F19B2848 71F19D0451 71F19E0081 71F19F0245 71F19J1235 71F19B0707 71F19C0406 71F19D0826 71F19E0998 71F19F0482 71F19J2164 71F19B0935 71F19C2047 71F19D1267 71F19E1253 71F19G1938 71F19K2878 71F19B1484 71F19C2433 71F19D2474 71F19E1315 71F19G2556 71F19B1832 71F19D0055 71F19D2761 71F19E2505 71F19H2404 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1202-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.